| Stage | DORM | % of rev | AVNT | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $562M | 100.00% | $917M | 100.00% | AVNT ×1.63 |
| Gross profit | $222M | 39.45% | $308M | 33.54% | DORM +5.9pp |
| Operating income | $83M | 14.76% | $112M | 12.26% | DORM +2.5pp |
| Pre-tax income | $77M | 13.77% | $89M | 9.72% | DORM +4.1pp |
| Net income | $59M | 10.53% | $66M | 7.16% | DORM +3.4pp |
| Stage | DORM | AVNT | Gap · A − B |
|---|---|---|---|
| Revenue | $562M100.00% | $917M100.00% | AVNT ×1.63 |
| Gross profit | 39.45%$222M | 33.54%$308M | DORM +5.9pp |
| Operating income | 14.76%$83M | 12.26%$112M | DORM +2.5pp |
| Pre-tax income | 13.77%$77M | 9.72%$89M | DORM +4.1pp |
| Net income |
| 10.53%$59M |
| 7.16%$66M |
| DORM +3.4pp |
No disclosed counterparties: DORM, AVNT.